Navigation Links
CWRU dental researchers discover how an oral bacterium can trigger colorectal cancer
Date:8/14/2013

Researchers from Case Western Reserve University School of Dental Medicine have discovered how a common oral bacterium can contribute to colorectal cancer, a finding that opens promising new research avenues for the development of approaches to prevent and treat the disease.

"We found this cancer is linked to an infection from [the bacterium]," said Yiping Han, professor of periodontics at the dental school and the study's lead investigator. "This discovery creates the potential for new diagnostic tools and therapies to treat and prevent the cancer."

The results of the research appear in the current issue of Cell Host & Microbe, in conjunction with a second study from a different research group that highlights how the bacteria can speed the accumulation of cancerous cells.

The researchers also learned how to prevent the microorganism, called Fusobacterium nucleatum (Fn), from attaching to colon cells and potentially triggering a cascade of changes that can lead to cancer.

The latest findings advance research from 2011, in which Han and her team identified an adhesive molecule on Fn's surface, called FadA, which can attach to VE-cadherin, a cell receptor from the cadherin group on blood vessels.

As Han completed the work on FadA and VE-cadherin, researchers from Harvard University and the University of British Columbia discovered the presence of Fn was higher in malignant tumors compared to the surrounding tissue.

Han said she immediately suspected Fn interacted with cells in the colon similarly to those in blood vessels and shifted her lab's work to focus on colorectal cancer.

"This was one of those serendipitous scientific moments in making this discovery," Han said.

Because her lab was able to track Fn's ability to attach to the VE-cadherin receptor on blood vessels, Han said it didn't take long before her team found how FadA attached to the E-cadherin receptor on cells in the colon.

Subsequently, FadA's attachment to E-cadherin set in motion a protein called -catenin, which, among its many functions, produces two important actions in the cancer process: an inflammatory response that alters the immune system, and another that spurs cancer cell growth.

Han's lab designed a novel synthetic peptide that prevents FadA from attaching to E-cadherin and inciting actions that lead to cancer development.

They also found that the FadA gene levels are 10 to 100 times higher than normal in precancerous and malignant colon polyps.

Thus, Han said, "FadA can be used as a diagnostic marker for early detection of colon cancer. It can also be used to determine if treatment works effectively at reducing Fn load in the colon and the mouth."

A patent application has been filed on work associated with this research.

At the same time, Han emphasized that the results highlight the importance of oral health. Fn is an opportunistic bacterium that increases dramatically in gum disease.


'/>"/>

Contact: Susan Griffith
susan.griffith@case.edu
216-368-1004
Case Western Reserve University
Source:Eurekalert

Related medicine news :

1. Assist to Succeed Holds Open House for New Dental Career Opportunity
2. CE Lectures on the Dental Treatment of Snoring and Sleep Apnea Include Rochester, Cleveland and Ft. Lauderdale, as Sleep Seminar Destinations
3. Mint Dental Alaska Announces Special Offers for New and Current Customers
4. Dallas, TX Gum Disease Treatment Can Now Help Prevent Tooth Loss and Prepare the Mouth for Dental Implants with Laser Gum Surgery from Dr. Michael Neeley
5. LSUHSC Dental School awarded $1.8 million for HIV care and education
6. Greenville Oral & Maxillofacial Surgeons Now Treating Removable Dentures with Dental Implants
7. Parlin Dentist Brings Emergency Dental Relief to Local Residents
8. Herald Square Dental Offers Relief from Obstructive Sleep Apnea
9. DentalSpots.com Expands Network Capabilities to Help Fill Texas Dental Jobs
10. Chicago Dentist Jessica Emery Offers Sedation Dentistry Outreach Programs During July to Those with Dental Phobias
11. California Dental Association Offers Tips to Avoid Dental Emergencies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Announced that ... clinical and commercial support services market) has entered into an agreement on September ... , The PGSD is the first private Dental School to launch an ...
(Date:9/20/2017)... ... September 20, 2017 , ... Each year Athletic ... National Athletic Trainers’ Association Annual Clinical Symposium and Expo. New research is revealed, ... when Athletic Trainers are acknowledged by their peers with accolades and highly prestigious ...
(Date:9/20/2017)... ... September 20, 2017 , ... Five consumer packaged goods (CPG) products were selected ... different categories. Nopavera Plus was named to the short list in the ... West 2017 during presentations at SupplySide Central on Sept. 27 and 28 at Mandalay ...
(Date:9/20/2017)... ... ... Health & Safety Institute (HSI) is offering discounted pricing on its Summit ... now until November 30, 2017 to assist with the clean-up efforts from hurricanes Harvey ... and government agencies – whether or not they will be directly involved in the ...
(Date:9/20/2017)... ... September 20, 2017 , ... “RECYCLED Ezekiel's Plan for Freedom ... Freedom from ADDICTION” is the creation of published author, Bill Miller. Bill ... homeless services, including more than a decade of addiction to prescription drugs. ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical ... Suicidal Ideation and Behavior (ASIB), has been granted Fast Track ... sequential therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine ... a pivotal trial of this sequential therapy targeting patients who ... 1 ...
(Date:9/5/2017)... Pa. , Sept. 5, 2017  Xyntek Inc. has announced another milestone ... a new Midwest office to meet the growing demands of customer engagements regionally.  ... Xyntek's new Midwest office is located at 318 ... ... of customer engagements regionally. ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... company focused on the development of oral drug delivery ... meeting with the U.S. Food and Drug Administration (FDA) ... At the meeting, the ... submission of ORMD-0801, would be a Biologics License Application ...
Breaking Medicine Technology: